A Practical Guide to Constructing and Using Tissue Microarrays

Methods in Molecular Biology

Volumn 675, Issue , 2011, Pages 363-373

  Chandler, Ian ^a   Houlston, Richard ^b   Landberg, Göran ^c  

^a Royal Cancer Hospital Cancer Genetics   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antigen heterogeneity; Image analysis; Immuno his tochemistry; Tissue core; Tissue microarray

Indexed keywords

ARTICLE; COMPUTER PROGRAM; HUMAN; IMMUNOHISTOCHEMISTRY; METHODOLOGY; MICROARRAY ANALYSIS;

HUMANS; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; SOFTWARE;

MLCS; MLOWN;

EID: 79952117850     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-59745-423-0_22     Document Type: Chapter

References (20)

1. Gulmann, C., Loring, P., O’Grady, A., and Kay, E. (2004) Miniature tissue microarrays for HercepTest standardisation and analysis. J Clin Path 57, 1229–1231.
2. Nielsen, T.O., Hsu, F.D., Jensen, K., Cheang, M., Karaca, G., Hu, Z., et al. (2004) Immunohistochemical and clinical characterisa-tion of the basal-like subtype of invasive breast carcinoma. Clin Ca Res 10, 5367–5374.
3. Deutsch, E.W., Ball, C.A., Bova, G.S., Brazma, A., Bumgarner R.E., Campbell, D., et al. (2006) Development of the minimum information specification for in situ hybridization and immunohistochemistry experiments (MISFISHIE). OMICS 10, 205–208.
4. Camp, R.L., Chung, G.G., and Rimm, D.L. (2002) Automated subcellular localization and quantification of protein expression in tissue microarrays. Nature Medicine 8, 1323–1328.
5. Jhavar, S., Corbishley, C.M., Dearnaley, D., Fisher, C., Falconer, A., Parker, C., et al. (2004) Construction of tissue microarrays from prostate needle biopsy specimens. Br J Cancer 93, 478–482.
6. Yang, X.R., Charette, L.A., Garcia-Closas, M, Lissowska, J., Paal, E., Sidawy, M., et al. (2006) Construction and validation of tissue microarrays of ductal carcinoma in situ and terminal duct lobular units associated with invasive breast carcinoma. Diagn Mol Pathol 15, 157–162.
7. DiVito, K.A., Berger, A.J., Camp, R.L., Dolled-Filhart, M., Rimm, D.L., and Kluger, H.M. (2004) Automated quantitative analysis of tissue microarrays reveals an association between high Bcl-2 expression and improved outcome in melanoma. Cancer Res 64, 8773–8777.
8. Aubele, M., Mattis, A., Zitzelsberger, H., Walck, A., Kremer, M., Hutzler, P., et al. (1999) Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridisation. Cancer Genet Cytogenet 110, 94–102.
9. Trudel, M., Mulligan, L., Cavenee, W., Margolese, R., Cote, J., and Gariepy, G. (1992) Retinoblastoma and p53 gene product expression in breast carcinoma. Hum Pathol 23, 1388–1394.
10. Quirke, P., Dyson, J.E.D., Dixon, M.F., Bird, C.C., and Joslin, C.A.F. (1985) Heterogeneity of colorectal adenocarcinomas evaluated by flow cytometry and histopathology. Br J Cancer 51, 99–106.
11. Losi, L., Baisse, B., Bouzourene, H., and Benhattar, J. (2005) Evolution of intratumoral genetic heterogeneity during colorectal cancer progression. Carcinogenesis 26, 916–922.
12. Samowitz, W.S., and Slattery, M.L. (1999) Regional reproducibility of microsatellite instability in sporadic colorectal cancer. Genes Chromosomes Cancer 26, 106–114.
13. Torhorst, J., Bucher, C., Kononen, J., Haas, P., Zuber, M., Kochli, O.R., et al. (2001) Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 159, 2249–2256.
14. Aaltonen, K., Ahlin, C., Amini, R.M., Salonen, L., Fjallskog, M.L., Heikkila, P., et al. (2006) Reliability of cyclin A assessment on tissue microarrays in breast cancer compared to conventional histological slides. Br J Cancer 94, 1697–1702.
15. Bhargava, R., Gerald, W.L., Li, A.R., Pan, Q., Lal, P., Ladanyi, M., et al. (2005) EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations. Mod Pathol 18, 1027–1033.
16. Loring, P., Cummins, R., O’Grady, A., Kay, E.W. (2005) HER2 positivity in breast carcinoma: a comparison of chromogenic in situ hybridisation with fluorescent in situ hybridisation in tissue microarrays, with targeted evaluation of intratumoural heterogeneity by in situ hybridisation. Appl Immunohistochem Mol Morphol 13, 194–200.
17. Kay, E., O’Grady, A., Morgan, J.M., Wozniak, S., and Jasani, B. (2004) Use of tissue microarray for interlaboratory validation of HER2 immunocytochemical and FISH testing. J Clin Pathol 57, 1140–1144.
18. Press, M.F., Slamon, D.J., Flom, K.J., Park, J., Zhou, J.Y., and Bernstein, L. (2002) Evaluation of HER-2/neu gene amplification and overexpression: comparison of frequently used assay methods in a molecularly characterized cohort of breast cancer specimens. J Clin Onco 20, 3095–3105.
19. Ricardo, S., Milanezi, F., Carvalho, S., Leitao, D., and Schmitt, F. (2006) HER2 evaluation through the novel rabbit monoclonal antibody SP3 and CISH in tissue microarrays of invasive breast carcinomas. J Clin Pathol 60(9), 1001–1005.
20. Sapino, A., Marchio, C., Senetta, R., Castellano, I., Macri, L., Cassoni, P., et al. (2006) Routine assessment of prognostic factors in breast cancer using a multicore tissue microarray procedure. Virchows Arch 449, 288–296.